ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. — Investor Relations & Filings
Anhui Anke Biotechnology (Group) Co., Ltd. is a high-tech enterprise specializing in the research, development, production, and commercialization of biopharmaceutical products. The company focuses on genetic engineering, cell therapy, and precision medicine. Its core product portfolio includes recombinant human growth hormone (rhGH) marketed under the brand Ansomone, and recombinant human interferon alpha-2b known as Anterferon. Anke Bio also develops diagnostic reagents, including biochemical and molecular diagnostic kits, and provides services in the fields of oncology and reproductive health. The company maintains a strong emphasis on innovation through its dedicated R&D centers, aiming to provide advanced therapeutic solutions for growth disorders, viral infections, and various cancers. Its operations span the entire value chain from basic research to clinical application and market distribution.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 2025年度利润分配方案 | 2026-03-30 | Chinese | |
| 董事会对会计师事务所2025年度履职情况的评估报告及审计委员会对会计师事务所履行监督职责情况的报告 | 2026-03-30 | Chinese | |
| 2025年度非经营性资金占用及其他关联资金往来情况专项说明 | 2026-03-30 | Chinese | |
| 2025年年度审计报告 | 2026-03-30 | Chinese | |
| 2025年年度报告 | 2026-03-30 | Chinese | |
| 2025年年度报告摘要 | 2026-03-30 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 36129696 | 2025年度利润分配方案 | 2026-03-30 | Chinese | ||
| 36129695 | 董事会对会计师事务所2025年度履职情况的评估报告及审计委员会对会计师事务所履行监督职责情况的报告 | 2026-03-30 | Chinese | ||
| 36129694 | 2025年度非经营性资金占用及其他关联资金往来情况专项说明 | 2026-03-30 | Chinese | ||
| 36129692 | 2025年年度审计报告 | 2026-03-30 | Chinese | ||
| 36129691 | 2025年年度报告 | 2026-03-30 | Chinese | ||
| 36129689 | 2025年年度报告摘要 | 2026-03-30 | Chinese | ||
| 36129688 | 独立董事2025年度述职报告（汪律） | 2026-03-30 | Chinese | ||
| 36129687 | 董事、高级管理人员薪酬管理制度(2026年3月) | 2026-03-30 | Chinese | ||
| 36129686 | 安徽天禾律师事务所关于安徽安科生物工程（集团）股份有限公司第三期限制性股票激励计划首次授予部分及预留授予部分限制性股票解除限售条件成就情况及回购注销部分限制性股票相关事项之法律意见书 | 2026-03-30 | Chinese | ||
| 36129684 | 关于第三期限制性股票激励计划抗肿瘤事业部获授人员首次授予股票第二个解除限售期和预留授予股票第二个解除限售期解除限售条件未成就及回购部分限制性股票的公告 | 2026-03-30 | Chinese | ||
| 36129682 | 关于使用闲置自有资金进行现金管理的公告 | 2026-03-30 | Chinese | ||
| 36129680 | 第九届董事会薪酬和考核委员会2026年第一次会议决议 | 2026-03-30 | Chinese | ||
| 36129679 | 关于第九届董事会第二次会议决议的公告 | 2026-03-30 | Chinese | ||
| 36129678 | 独立董事2025年度述职报告（刘光福） | 2026-03-30 | Chinese | ||
| 36129676 | 独立董事2025年度述职报告（朱卫东） | 2026-03-30 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/55035/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=55035 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=55035 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=55035 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 55035}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for ANHUI ANKE BIOTECHNOLOGY (GROUP)CO.,LTD. (id: 55035)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.